Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists. [electronic resource]
Producer: 20070817Description: 282-91 p. digitalISSN:- 0376-8716
- Analgesics, Opioid -- pharmacokinetics
- Animals
- Binding, Competitive
- Brain -- drug effects
- Dopamine -- metabolism
- Dose-Response Relationship, Drug
- Enkephalin, Ala(2)-MePhe(4)-Gly(5)- -- pharmacokinetics
- Guinea Pigs
- In Vitro Techniques
- Lobeline -- pharmacology
- Mecamylamine -- pharmacology
- Morphine -- pharmacology
- Naltrexone -- pharmacology
- Narcotic Antagonists -- pharmacology
- Narcotics -- pharmacology
- Nicotine -- pharmacology
- Oocytes
- Radioligand Assay
- Receptors, Opioid -- drug effects
- Receptors, Opioid, mu -- drug effects
- Xenopus laevis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.